Adjuvant therapy and recurrence risk in non-myoinvasive high-grade (stage IC) endometrial cancer: A systematic review and meta-analysis.
Mary Katherine AnastasioAngela NolinKatherine N PenvoseKatherine LambertJessie LiLeila LedbetterBrittany A DavidsonLaura J HavrileskyBenjamin B AlbrightPublished in: Gynecologic oncology (2024)
Among patients with non-myoinvasive high-grade endometrial cancer, recurrence risk was 11 % and use of adjuvant therapy was not associated with reduced recurrence risk. Prospective study of this population is warranted.